The present invention relates to an agent for improving renal dysfunction comprising as an active ingredient a compound represented by the following formula (1):wherein each R1, R2, and R3 represents a hydrogen atom or a methyl group, and X represents a linear or branched alkylene or alkenylene group having 10 to 28 carbon atoms.